WIB22: Hear from our 2022 Women in Bio­phar­ma R&D hon­orees, and catch our pan­el on em­pow­er­ing women

If we’ve learned any­thing from our an­nu­al Women in Bio­phar­ma R&D re­port over the last four years, it’s that there’s much to cel­e­brate.

We re­ceived more than 500 nom­i­na­tions this year high­light­ing ex­tra­or­di­nary women who are blaz­ing trails in drug de­vel­op­ment. While se­lect­ing just 20 hon­orees has be­come in­creas­ing­ly dif­fi­cult, we were thrilled to de­but this year’s group with you last week. They’re sci­en­tists, CEOs, re­searchers and more who have de­vel­oped new drugs for rare and life-threat­en­ing dis­eases, changed the way we think about com­mon con­di­tions such as mi­graine, and bro­ken bound­aries.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER